4-chloropyrropyrimidine is an important pharmaceutical intermediate that is used, for example, as an intermediate for the treatment of tofacitinib in adult patients with..
Sunitinib is a small molecule multi-target tyrosine kinase inhibitor and the first in a new class of drugs that can selectively target multiple receptor tyrosine kinases.